Ceribell (CBLL) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Ceribell (CBLL) do?
Ceribell Inc (CBLL) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures portable brain monitoring devices for emergency departments and intensive care units. It builds rapid-response brain monitors using disposable headbands and artificial intelligence to detect bedside. It is worth $1.00B on the market and sold $108.70M over the last year.
- Market cap
- $1.00B
- P/E ratio
- None (reported a loss)
- Annual sales
- $108.70M
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 19, 2026
Brands and businesses behind CBLL
- Clarity: Provides automated brainwave interpretation to alert bedside medical teams when patients suffer non-convulsive seizures.
CBLL’s flags, in plain English
Each flag is a number from Ceribell’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Stupid Cash
Can pay this year's bills 8.1 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Wide Gross Margin
Gross margin of 89.3% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Insiders Hold
Insiders own 33.4% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Burning Cash
Losing money, profit margin of -68%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about CBLL
How big is Ceribell?
Ceribell’s market cap is $1.00B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $108.70M: what customers paid the company over the last year, before any costs.
What is CBLL’s P/E ratio?
CBLL has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with CBLL?
The business depends almost entirely on a single monitoring platform and its compatible disposable headbands for revenue. That is one risk on Ceribell’s card. Its first risk flag is Burning Cash, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Ceribell’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. CBLL’s filings on SEC.gov. The Margin Monkey is research, not advice.
